K-ATP Channel Closure Ameliorates the Impaired Insulinotropic Effect of Glucose-Dependent Insulinotropic Polypeptide in Patients with Type 2 Diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

K-ATP Channel Closure Ameliorates the Impaired Insulinotropic Effect of Glucose-Dependent Insulinotropic Polypeptide in Patients with Type 2 Diabetes. / Aaboe, K.; Knop, K.; Vilsboll, T.; Volund, A.; Simonsen, U.; Deacon, C.F.; Madsbad, S.; Holst, J.J.; Krarup, T.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 94, No. 2, 2009, p. 603-608.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Aaboe, K, Knop, K, Vilsboll, T, Volund, A, Simonsen, U, Deacon, CF, Madsbad, S, Holst, JJ & Krarup, T 2009, 'K-ATP Channel Closure Ameliorates the Impaired Insulinotropic Effect of Glucose-Dependent Insulinotropic Polypeptide in Patients with Type 2 Diabetes', Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 2, pp. 603-608.

APA

Aaboe, K., Knop, K., Vilsboll, T., Volund, A., Simonsen, U., Deacon, C. F., Madsbad, S., Holst, J. J., & Krarup, T. (2009). K-ATP Channel Closure Ameliorates the Impaired Insulinotropic Effect of Glucose-Dependent Insulinotropic Polypeptide in Patients with Type 2 Diabetes. Journal of Clinical Endocrinology and Metabolism, 94(2), 603-608.

Vancouver

Aaboe K, Knop K, Vilsboll T, Volund A, Simonsen U, Deacon CF et al. K-ATP Channel Closure Ameliorates the Impaired Insulinotropic Effect of Glucose-Dependent Insulinotropic Polypeptide in Patients with Type 2 Diabetes. Journal of Clinical Endocrinology and Metabolism. 2009;94(2):603-608.

Author

Aaboe, K. ; Knop, K. ; Vilsboll, T. ; Volund, A. ; Simonsen, U. ; Deacon, C.F. ; Madsbad, S. ; Holst, J.J. ; Krarup, T. / K-ATP Channel Closure Ameliorates the Impaired Insulinotropic Effect of Glucose-Dependent Insulinotropic Polypeptide in Patients with Type 2 Diabetes. In: Journal of Clinical Endocrinology and Metabolism. 2009 ; Vol. 94, No. 2. pp. 603-608.

Bibtex

@article{e5542530af6c11df825b000ea68e967b,
title = "K-ATP Channel Closure Ameliorates the Impaired Insulinotropic Effect of Glucose-Dependent Insulinotropic Polypeptide in Patients with Type 2 Diabetes",
abstract = "Objective: The reduced incretin effect in subjects with type 2 diabetes is accompanied by a severely impaired insulinotropic effect of the incretin hormone glucose-dependent insulinotropic polypeptide (GIP). The K-ATP channels of the beta-cell appear to be essential for the function of GIP in mice, and mutations in the gene encoding these channels have been linked to the development of type 2 diabetes. With this study we therefore aimed at clarifying the role of K-ATP channel malfunction in the impaired function of GIP. Research Design and Methods: We examined 12 subjects with type 2 diabetes using a 2-h (15 mM) hyperglycemic clamp on 4 separate days with concomitant infusion of one of the following: GIP; GIP + 10 mg sulfonylurea (SU, glipizide) taken orally 1 h before the clamp; saline + 10 mg SU; or saline alone. Blood was sampled to measure plasma concentrations of glucose, intact GIP, insulin, C-peptide, and glucagon. Results: Compared to the results of GIP alone, SU alone, or those results added together, coadministration of GIP and SU resulted in a more-than-additive increase in the peripheral insulin (P = 0.002) and C-peptide (P = 0.028) responses and furthermore, a more-than-additive increase in total (P = 0.01), early (P = 0.02), and late-phase (P = 0.02) insulin secretion. Conclusion: We have demonstrated that inhibiting the K-ATP channels of the diabetic beta-cell acutely using SU significantly increases both the peripheral insulin response to GIP and GIP-induced insulin secretion, indicating an ameliorated insulinotropic effect of GIP. (J Clin Endocrinol Metab 94: 603-608, 2009) Udgivelsesdato: 2009",
author = "K. Aaboe and K. Knop and T. Vilsboll and A. Volund and U. Simonsen and C.F. Deacon and S. Madsbad and J.J. Holst and T. Krarup",
note = "JFEB",
year = "2009",
language = "English",
volume = "94",
pages = "603--608",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "Oxford University Press",
number = "2",

}

RIS

TY - JOUR

T1 - K-ATP Channel Closure Ameliorates the Impaired Insulinotropic Effect of Glucose-Dependent Insulinotropic Polypeptide in Patients with Type 2 Diabetes

AU - Aaboe, K.

AU - Knop, K.

AU - Vilsboll, T.

AU - Volund, A.

AU - Simonsen, U.

AU - Deacon, C.F.

AU - Madsbad, S.

AU - Holst, J.J.

AU - Krarup, T.

N1 - JFEB

PY - 2009

Y1 - 2009

N2 - Objective: The reduced incretin effect in subjects with type 2 diabetes is accompanied by a severely impaired insulinotropic effect of the incretin hormone glucose-dependent insulinotropic polypeptide (GIP). The K-ATP channels of the beta-cell appear to be essential for the function of GIP in mice, and mutations in the gene encoding these channels have been linked to the development of type 2 diabetes. With this study we therefore aimed at clarifying the role of K-ATP channel malfunction in the impaired function of GIP. Research Design and Methods: We examined 12 subjects with type 2 diabetes using a 2-h (15 mM) hyperglycemic clamp on 4 separate days with concomitant infusion of one of the following: GIP; GIP + 10 mg sulfonylurea (SU, glipizide) taken orally 1 h before the clamp; saline + 10 mg SU; or saline alone. Blood was sampled to measure plasma concentrations of glucose, intact GIP, insulin, C-peptide, and glucagon. Results: Compared to the results of GIP alone, SU alone, or those results added together, coadministration of GIP and SU resulted in a more-than-additive increase in the peripheral insulin (P = 0.002) and C-peptide (P = 0.028) responses and furthermore, a more-than-additive increase in total (P = 0.01), early (P = 0.02), and late-phase (P = 0.02) insulin secretion. Conclusion: We have demonstrated that inhibiting the K-ATP channels of the diabetic beta-cell acutely using SU significantly increases both the peripheral insulin response to GIP and GIP-induced insulin secretion, indicating an ameliorated insulinotropic effect of GIP. (J Clin Endocrinol Metab 94: 603-608, 2009) Udgivelsesdato: 2009

AB - Objective: The reduced incretin effect in subjects with type 2 diabetes is accompanied by a severely impaired insulinotropic effect of the incretin hormone glucose-dependent insulinotropic polypeptide (GIP). The K-ATP channels of the beta-cell appear to be essential for the function of GIP in mice, and mutations in the gene encoding these channels have been linked to the development of type 2 diabetes. With this study we therefore aimed at clarifying the role of K-ATP channel malfunction in the impaired function of GIP. Research Design and Methods: We examined 12 subjects with type 2 diabetes using a 2-h (15 mM) hyperglycemic clamp on 4 separate days with concomitant infusion of one of the following: GIP; GIP + 10 mg sulfonylurea (SU, glipizide) taken orally 1 h before the clamp; saline + 10 mg SU; or saline alone. Blood was sampled to measure plasma concentrations of glucose, intact GIP, insulin, C-peptide, and glucagon. Results: Compared to the results of GIP alone, SU alone, or those results added together, coadministration of GIP and SU resulted in a more-than-additive increase in the peripheral insulin (P = 0.002) and C-peptide (P = 0.028) responses and furthermore, a more-than-additive increase in total (P = 0.01), early (P = 0.02), and late-phase (P = 0.02) insulin secretion. Conclusion: We have demonstrated that inhibiting the K-ATP channels of the diabetic beta-cell acutely using SU significantly increases both the peripheral insulin response to GIP and GIP-induced insulin secretion, indicating an ameliorated insulinotropic effect of GIP. (J Clin Endocrinol Metab 94: 603-608, 2009) Udgivelsesdato: 2009

M3 - Journal article

VL - 94

SP - 603

EP - 608

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 2

ER -

ID: 21544542